Manufacturing difficulties are holding back the commercial development of heart disease cell therapies, according to researchers who say “cell free” treatment could be an easy-to-make alternative. A ...
With a flexible, no-equipment-needed platform, ChBE researchers are creating a new way to test for disease at home or anywhere medical resources are limited. The team's modular cell-free protein ...
In this interview, we speak with Angeline Lim, PhD, Senior Application Scientist at Molecular Devices, about the role of AI and automation in modern drug discovery. Angeline shares how Molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results